Projects per year
Personal profile
Education
- 2002 Ph.D. National Taiwan University
- 1994 M.S. Taipei Medical University
Experience
- 2023- Dean, College of Medical Science and Technology, Taipei Medical University
- 2020-2023 Vice Dean, College of Medical Science and Technology, Taipei Medical University
- 2019-2022 Director, Ph.D. Program in Drug Discovery and Development Industry, Taipei Medical University
- 2018- Professor, Master Program in Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University
- 2017- Professor, Ph.D. Program in Biotechnology Research and Development, , Taipei Medical University
- 2016-2018 Professor, Ph.D. Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
- 2013-2016 Associate Professor, Ph.D. Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
- 2008-2013 Assistant Professor, Department of Pharmacology, Taipei Medical University
- 2009-2013 Assistant Investigator, National Health Research Institutes
- 2007-2009 Assistant Investigator, National Taiwan University
- 2002-2007 Postdoctor, National Taiwan Universiy
- 1994-1998 Teaching Assistant, Chang-Gung University
Awards
- 2019 Single Research Project Budget Award, Taipei Medical University
Research Interests
- Drug Discovery
- Disease animal model
- Pharmacology
Related Link
Fingerprint
Dive into the research topics where Shiow-Lin Pan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Investigating Potential Biomarkers and Mechanisms of Hdac6 Inhibitors in the Treatment of Human Lung Adenocarcinoma
Pan, S.-L. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Evaluating the Mechanism and Therapeutic Potential of Dyrk1/Clk Inhibitors Modulating Mrna Splicing in Human Digestive Cancers( III )
Pan, S.-L. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
探討新穎性CK1抑制劑對膠質母細胞瘤之抗癌效果與作用機轉
Pan, S.-L. (PI)
7/1/25 → 2/28/26
Project: A - Government Institution › b - National Science and Technology Council
-
研發新穎性治療乳癌藥物與機轉探討
Pan, S.-L. (PI)
7/1/25 → 2/28/26
Project: A - Government Institution › b - National Science and Technology Council
-
開發調控 RNA splicing 之新穎抑制劑應用於胰臟癌治療
Pan, S.-L. (PI)
1/1/25 → 12/31/25
Project: B - Project of TMU › h - Higher Education Sprout Project
-
Discovery of a novel RSK2 inhibitor for the treatment of metastatic pancreatic cancer
Chung, C. H., Hsu, K. C., Huang, M. M., Tu, H. J., Pan, S. L. & Chao, M. W., Dec 31 2025, In: Journal of Enzyme Inhibition and Medicinal Chemistry. 40, 1, 2538673.Research output: Contribution to journal › Article › peer-review
-
Exploring diarylheptanoid derivatives to target LIMK1 as potential agents against colorectal cancer
Chen, L. C., Chang, T. C., Tseng, H. J., Chu, J. C., Huang, Y. Y., Peng, H. Y., Kuo, Y. C., Wu, Y. W., Lin, T. E., Yen, S. C., Hsu, K. C., Huang, W. J. & Pan, S. L., 2025, In: Journal of Enzyme Inhibition and Medicinal Chemistry. 40, 1, 2583826.Research output: Contribution to journal › Article › peer-review
Open Access -
Identification and Biological Evaluation of a Novel CLK4 Inhibitor Targeting Alternative Splicing in Pancreatic Cancer Using Structure-Based Virtual Screening
Yang, C. L., Wu, Y. W., Tu, H. J., Yeh, Y. H., Lin, T. E., Sung, T. Y., Li, M. C., Yen, S. C., Hsieh, J. H., Yu, M. C., Hsieh, S. Y., Hsieh, H. P., Pan, S. L. & Hsu, K. C., May 1 2025, In: Advanced Science. 12, 19, p. e2416323 1 p., 2416323.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Identification of a Potent CDK8 Inhibitor Using Structure-Based Virtual Screening
Lin, T. E., Chou, C. H., Wu, Y. W., Sung, T. Y., Hsu, J. Y., Yen, S. C., Hsieh, J. H., Chang, Y. W., Pan, S. L., Huang, W. J., Hsu, K. C. & Yang, C. R., Jan 13 2025, In: Journal of Chemical Information and Modeling. 65, 1, p. 378-389 12 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Identification of pyrazole scaffold inhibitors targeting cyclin-dependent kinase 8 for potential use in pulmonary fibrosis
Lin, T. E., Hsu, K. C., Chou, C. H., Tsai, E. Y., Wu, Y. W., Sung, T. Y., Hsu, J. Y., Hsieh, J. H., Yen, S. C., Chang, Y. W., Pan, S. L., Huang, W. J. & Yang, C. R., Jul 2025, In: Biochemical Pharmacology. 237, 116959.Research output: Contribution to journal › Article › peer-review
Datasets
-
The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells
Tu, H.-J. (Contributor), Lin, Y.-J. (Contributor), Chao, M.-W. (Contributor), Sung, T.-Y. (Creator), Wu, Y.-W. (Creator), Chen, Y.-Y. (Creator), Lin, M.-H. (Contributor), Liou, J.-P. (Creator), Pan, S.-L. (Contributor) & Yang, C.-R. (Contributor), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4350887.v1, https://springernature.figshare.com/collections/The_anticancer_effects_of_MPT0G211_a_novel_HDAC6_inhibitor_combined_with_chemotherapeutic_agents_in_human_acute_leukemia_cells/4350887/1
Dataset
-
Additional file 1 of Investigating the potential effects of selective histone deacetylase 6 inhibitor ACY1215 on infarct size in rats with cardiac ischemia-reperfusion injury
Pan, S.-L. (Contributor), Hsu, K.-C. (Creator), Lin, T. E. (Creator), Lin, C.-F. (Creator), Huang, H.-L. (Contributor) & Huangfu, W.-C. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.11992497.v1, https://doi.org/10.6084%2Fm9.figshare.11992497.v1
Dataset
-
Additional file 5: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chang, L.-H. (Contributor), Liou, J.-P. (Creator), Lai, M.-J. (Contributor), Chang, C.-D. (Contributor), Tu, H.-J. (Contributor), Chao, M.-W. (Contributor), Pan, S.-L. (Contributor), Chen, Y.-Y. (Creator) & Teng, C.-M. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.8202902.v1, https://doi.org/10.6084%2Fm9.figshare.8202902.v1
Dataset
-
Additional file 4: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chao, M.-W. (Contributor), Chang, L.-H. (Contributor), Tu, H.-J. (Contributor), Chang, C.-D. (Contributor), Lai, M.-J. (Contributor), Chen, Y.-Y. (Creator), Liou, J.-P. (Creator), Teng, C.-M. (Contributor) & Pan, S.-L. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.8202896.v1, https://springernature.figshare.com/articles/Additional_file_4_of_Combination_treatment_strategy_for_pancreatic_cancer_involving_the_novel_HDAC_inhibitor_MPT0E028_with_a_MEK_inhibitor_beyond_K-Ras_status/8202896/1
Dataset
-
Additional file 1 of EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody
Cheng, Y.-W. (Creator), Cheng, C.-C. (Creator), HuangFu, W.-C. (Creator), Pan, S.-L. (Creator), Sung, T.-Y. (Creator), Chang, F.-L. (Creator), Huang, H.-L. (Contributor), Huang, C.-C. (Contributor), Wei, P.-L. (Contributor) & Lee, Y.-C. (Contributor), Figshare, 2021
DOI: 10.6084/m9.figshare.14228278.v1, https://doi.org/10.6084%2Fm9.figshare.14228278.v1
Dataset